LONDON, Aug. 8, 2016 /PRNewswire/ -- United States Market for In Vitro Diagnostic Tests takes a considered look at the U.S. in vitro diagnostics (IVD) market and examines what current market trends mean for diagnostic manufacturers and investors. This report includes important tools for business planners. Included are market size estimates and forecasts for the following U.S. IVD segments:
- Clinical Chemistry Market (2015/2020)
- Identification and Antibiotic Susceptibility Testing (ID/AST) Microbiology (Traditional) Market Automated ID/AST, Manual/SemiAuto ID/AST, Blood Culture, Chromogenic Media, Rapid Micro (2015/2020)
- Molecular Microbiology / Virology Market HAIs/BSIs, HIV, Hepatitis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other (2015/2020)
- Point-of-Care (POC) Diagnostics Markets Professional (Drugs of Abuse, Infectious Disease, Pregnancy, Glucose, HbA1c, Lipids, Cardiac Markers, FOB, Critical Care, Coagulation, Hematology, Other), OTC Diabetes, OTC Other (2015/2020)
- Immunoassays Market Non Infectious (Cardiac Markers, Tumor Markers, HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D) (2015/2020)
- Immunoassays Market Infectious (Hepatitis, HIV, STDs, ToRCH, Respiratory, HAIs/Sepsis, Parasitology, Mycology, Others) (2015/2020)
- Urinalysis Lab Diagnostics Market (2015/2020)
- Molecular Diagnostics Market (2015/2020)
- Coagulation Diagnostics Market (2015/2020)
- Histology and Cytology Diagnostics Market (2015/2020)
- Hematology Diagnostics Market (2015/2020)
- Blood Testing and Typing Diagnostics Market (2015/2020)
- Clinical Flow Cytometry Market (2015/2020)
The United States represents the world's largest in vitro diagnostics (IVD) market, projected to outpace other IVD markets in the developed world such as Western Europe and Japan. The report discusses market factors and trends, including: - continued expansion of the insured population under the ACA and increased healthcare utilization baselines;
- demographic aging that increases demand for clinical testing paid for through the country's leading vehicle for lab payments (Medicare);
- relatively optimistic macroeconomic indicators vis-a -vis the domestic outlook five years ago or other developed markets in the world;
- continued product innovation and industry responsiveness to clients' needs in the world's largest IVD market.
The report tracks developments, both challenging and positive, in the United States IVD market. Conclusions about the market are made concerning issues such as distribution of market share in IVD market segments, future U.S. IVD market growth, anticipated market obstacles, the growth of the molecular diagnostics market, and core lab IVD market growth.
United States Market for In Vitro Diagnostic Tests profiles in-depth the top tier U.S. IVD market participants. The total combined IVD sales of these top tier companies are estimated by Kalorama to represent nearly 70% of the total U.S. IVD market. The report ranks these firms and notes the IVD strengths of each. Companies discussed include: - Danaher Corporation
- Roche Diagnostics
- Siemens Healthcare Diagnostics
Download the full report: https://www.reportbuyer.com/product/3971220/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article